2012 Fiscal Year Final Research Report
Posttranscriptional modification of cardiac transcriptional factors and its role in cardiac development
Project/Area Number |
22590803
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Circulatory organs internal medicine
|
Research Institution | The University of Tokyo |
Principal Investigator |
HIROI Yukio 東京大学, 医学部附属病院, 講師 (30311624)
|
Co-Investigator(Kenkyū-buntansha) |
KOIBUCHI Nobutaka 熊本大学, 医学系大学院, 助教 (30456131)
|
Project Period (FY) |
2010 – 2012
|
Keywords | 分子心臓病学 |
Research Abstract |
Tbx5 associates with DNA-PK complex (Ku70, KU80, and DNA-PKcs) and it is phosphorylated at Ser289 and Ser301. A DNA-PK inhibitor suppresses the activation of ANP promoter-luciferase and overexpression of either Ku70, Ku80,or DNA-PKcs increases . The mutation of S289A, S301A, and S289A/S301A decreases its ability to activate ANP promoter and synergistic effect with Nkx2-5.
|